Related references
Note: Only part of the references are listed.Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology
Yazmin Brown et al.
MATRIX BIOLOGY (2023)
Serum Exosomes From Epithelial Ovarian Cancer Patients Contain LRP1, Which Promotes the Migration of Epithelial Ovarian Cancer Cell
Wei Zhou et al.
MOLECULAR & CELLULAR PROTEOMICS (2023)
Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer
Amir Hossein Aalami et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2023)
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases
Elham Oveili et al.
CELL COMMUNICATION AND SIGNALING (2023)
Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer
Li Ning et al.
BMC CANCER (2022)
Cell-free DNA analysis in current cancer clinical trials: a review
M. Cisneros-Villanueva et al.
BRITISH JOURNAL OF CANCER (2022)
Secondary cytoreductive surgery for recurrent low-grade serous ovarian carcinoma: A systematic review and meta-analysis
Rebecca M. Goldberg et al.
GYNECOLOGIC ONCOLOGY (2022)
Recent Advances in Ovarian Cancer: Therapeutic Strategies, Potential Biomarkers, and Technological Improvements
Salima Akter et al.
CELLS (2022)
Potential clinical utility of liquid biopsies in ovarian cancer
Jie Wei Zhu et al.
MOLECULAR CANCER (2022)
The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination
Anna Szczerba et al.
CANCERS (2022)
The application of circulating tumor cell and cell-free DNA liquid biopsies in ovarian cancer
Abigel Balla et al.
MOLECULAR AND CELLULAR PROBES (2022)
Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma
Kosuke Yoshida et al.
CANCER SCIENCE (2021)
Combined Serum DKK3 and Circulating CDI33 Cells as Prognostic Cancer Patients
Xiao-Cui Nie et al.
ONCOTARGETS AND THERAPY (2021)
Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer
Carolina Maria Sassu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
Hana Storkanova et al.
SCIENTIFIC REPORTS (2021)
The biology, function, and applications of exosomes in cancer
Jinyi Liu et al.
ACTA PHARMACEUTICA SINICA B (2021)
Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
Mohammad Aslam Khan et al.
SEMINARS IN CANCER BIOLOGY (2021)
The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer-A Study of the OVCAD Consortium
Eva Obermayr et al.
CANCERS (2021)
Future Screening Prospects for Ovarian Cancer
Diana Zilovic et al.
CANCERS (2021)
Hypoxia and the Tumor Microenvironment
Yue Li et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2021)
Platelets: The Emerging Clinical Diagnostics and Therapy Selection of Cancer Liquid Biopsies
Yiming Meng et al.
ONCOTARGETS AND THERAPY (2021)
Genome-wide Copy-number Alterations in Circulating Tumor DNA as a Novel Biomarker for Patients with High-grade Serous Ovarian Cancer
Lara Paracchini et al.
CLINICAL CANCER RESEARCH (2021)
Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Du-Bois Asante et al.
CANCER LETTERS (2020)
Cell-Free DNA and Apoptosis: How Dead Cells Inform About the Living
Ellen Heitzer et al.
TRENDS IN MOLECULAR MEDICINE (2020)
Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer
Alka Singh et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Serum exosomal microRNA-34a as a potential biomarker in epithelial ovarian cancer
Kazuya Maeda et al.
JOURNAL OF OVARIAN RESEARCH (2020)
The Diagnosis, Treatment, Prognosis and Molecular Pathology of Borderline Ovarian Tumors: Current Status and Perspectives
Yu Sun et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Ovarian Carcinoma Histotype: Strengths and Limitations of Integrating Morphology With Immunohistochemical Predictions
Martin Kobel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2019)
Liquid biopsy and minimal residual disease - latest advances and implications for cure
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer
Corinna Keup et al.
CANCERS (2019)
circMAN1A2 could serve as a novel serum biomarker for malignant tumors
Chun-Mei Fan et al.
CANCER SCIENCE (2019)
Post-debulking circulating tumor cell as a poor prognostic marker in advanced stage ovarian cancer A prospective observational study
Miseon Kim et al.
MEDICINE (2019)
Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease
Roxane Mari et al.
CANCERS (2019)
Aberrant Methylation Status of Tumour Suppressor Genes in Ovarian Cancer Tissue and Paired Plasma Samples
Dana Dvorska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential
Tyler A. Allen et al.
JOURNAL OF CELL SCIENCE (2019)
Exosomes promote pre-metastatic niche formation in ovarian cancer
Wenlong Feng et al.
MOLECULAR CANCER (2019)
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
A. Gonzalez-Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Applications of liquid biopsies for cancer
Austin K. Mattox et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Vesicular-Bound HLA-G as a Predictive Marker for Disease Progression in Epithelial Ovarian Cancer
Esther Schwich et al.
CANCERS (2019)
Exosomal microRNA-205 is involved in proliferation, migration, invasion, and apoptosis of ovarian cancer cells via regulating VEGFA
Lijun Wang et al.
CANCER CELL INTERNATIONAL (2019)
Liquid biopsy in ovarian cancer: recent advances in circulating extracellular vesicle detection for early diagnosis and monitoring progression
Lei Chang et al.
THERANOSTICS (2019)
Prospective study of the efficacy and utility of TP53 mutations in circulating tumor DNA as a non-invasive biomarker of treatment response monitoring in patients with high-grade serous ovarian carcinoma
Yong-Man Kim et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Development of a Highly Sensitive Device for Counting the Number of Disease-Specific Exosomes in Human Sera
Yasuaki Kabe et al.
CLINICAL CHEMISTRY (2018)
ESR1 methylation in primary tumors and paired circulating tumor DNA of patients with high-grade serous ovarian cancer
Lydia Giannopoulou et al.
GYNECOLOGIC ONCOLOGY (2018)
Advances of exosome in the development of ovarian cancer and its diagnostic and therapeutic prospect
Jiayu Shen et al.
ONCOTARGETS AND THERAPY (2018)
Circulating cell-free DNA for non-invasive cancer management
Caitlin M. Stewart et al.
CANCER GENETICS (2018)
Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer
Yan-xiu Guo et al.
Oncotarget (2018)
Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker
Xuehui Zhang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Latest development of liquid biopsy
Alvin Ho-Kwan Cheung et al.
JOURNAL OF THORACIC DISEASE (2018)
Cancer of the ovary, fallopian tube, and peritoneum
Jonathan S. Berek et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2018)
Exosome-Based Cell-Cell Communication in the Tumor Microenvironment
Joana Maia et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
S. Siena et al.
ANNALS OF ONCOLOGY (2018)
Chromosomal Instability in Cell-Free DNA as a Highly Specific Biomarker for Detection of Ovarian Cancer in Women with Adnexal Masses
Adriaan Vanderstichele et al.
CLINICAL CANCER RESEARCH (2017)
Predictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancer
Maria Lee et al.
GYNECOLOGIC ONCOLOGY (2017)
Circular RNAs: A novel type of non-coding RNA and their potential implications in antiviral immunity
Man Wang et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
CircRNA: functions and properties of a novel potential biomarker for cancer
Shujuan Meng et al.
MOLECULAR CANCER (2017)
Integrating liquid biopsies into the management of cancer
Giulia Siravegna et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Direct detection of early-stage cancers using circulating tumor DNA
Jillian Phallen et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Exosomes: Key mediators of metastasis and pre-metastatic niche formation
Richard J. Lobb et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2017)
Tumor-derived exosomes in ovarian cancer - liquid biopsies for early detection and real-time monitoring of cancer progression
Shayna Sharma et al.
ONCOTARGET (2017)
ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
Issam Chebouti et al.
ONCOTARGET (2017)
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
Yuji Mishima et al.
CELL REPORTS (2017)
Liquid Biopsy: Current Status and Future Perspectives
Sonja Mader et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Liquid biopsies come of age: towards implementation of circulating tumour DNA
Jonathan C. M. Wan et al.
NATURE REVIEWS CANCER (2017)
Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis
Li Gong et al.
BIOMEDICINE & PHARMACOTHERAPY (2016)
Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening
Paul A. Cohen et al.
BMC MEDICINE (2016)
TNF-Related Apoptosis-Inducing Ligand (TRAIL)-Armed Exosomes Deliver Proapoptotic Signals to Tumor Site
Licia Rivoltini et al.
CLINICAL CANCER RESEARCH (2016)
Clinical relevance of circulating cell-free microRNAs in ovarian cancer
Koji Nakamura et al.
MOLECULAR CANCER (2016)
Cell-free DNA as a diagnostic marker for cancer: current insights
Samanta Salvi et al.
ONCOTARGETS AND THERAPY (2016)
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy
Catherine Alix-Panabieres et al.
CANCER DISCOVERY (2016)
Altered expression pattern of circular RNAs in primary and metastatic sites of epithelial ovarian carcinoma
Ikhlak Ahmed et al.
ONCOTARGET (2016)
Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer
Kyung-A Hyun et al.
ONCOTARGET (2016)
Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers
Faye R. Harris et al.
SCIENTIFIC REPORTS (2016)
Fragment Length of Circulating Tumor DNA
Hunter R. Underhill et al.
PLOS GENETICS (2016)
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study
Christine A. Parkinson et al.
PLOS MEDICINE (2016)
Application of Multiplex Nested Methylated Specific PCR in Early Diagnosis of Epithelial Ovarian Cancer
Bi Wang et al.
Asian Pacific Journal of Cancer Prevention (2015)
Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
Xiaodan Meng et al.
BRITISH JOURNAL OF CANCER (2015)
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics
Myron G. Best et al.
CANCER CELL (2015)
A novel serum microRNA panel to discriminate benign from malignant ovarian disease
Ream Langhe et al.
CANCER LETTERS (2015)
Exosomes: Emerging biomarkers and targets for ovarian cancer
Maggie K. S. Tang et al.
CANCER LETTERS (2015)
Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features
M. Zuberi et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Treatment monitoring of patients with epithelial ovarian cancer using invasive circulating tumor cells (iCTCs)
Michael L. Pearl et al.
GYNECOLOGIC ONCOLOGY (2015)
Serum microRNA-145 as a novel biomarker in human ovarian cancer
Huichao Liang et al.
TUMOR BIOLOGY (2015)
Quantitative analysis of cell-free DNA in ovarian cancer
Xuefeng Shao et al.
ONCOLOGY LETTERS (2015)
Personalized Circulating Tumor DNA Biomarkers Dynamically Predict Treatment Response and Survival In Gynecologic Cancers
Elena Pereira et al.
PLOS ONE (2015)
Aberrant Methylation of RASSF2A in Tumors and Plasma of Patients with Epithelial Ovarian Cancer
Yu Wu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
Jan Dominik Kuhlmann et al.
CLINICAL CHEMISTRY (2014)
Prognostic importance of cell-free DNA in chemotherapy resistant ovarian cancer treated with bevacizumab
Karina Dahl Steffensen et al.
EUROPEAN JOURNAL OF CANCER (2014)
Prognostic analysis of invasive circulating tumor cells (iCTCs) in epithelial ovarian cancer
Michael L. Pearl et al.
GYNECOLOGIC ONCOLOGY (2014)
Proteome-Metabolome Profiling of Ovarian Cancer Ascites Reveals Novel Components Involved in Intercellular Communication
Victoria O. Shender et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
OPINION Challenges in circulating tumour cell research
Catherine Alix-Panabieres et al.
NATURE REVIEWS CANCER (2014)
Identification of Serum MicroRNA-21 as a Biomarker for Early Detection and Prognosis in Human Epithelial Ovarian Cancer
Yun-Zhao Xu et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance - A study of the OVCAD consortium
Eva Obermayr et al.
GYNECOLOGIC ONCOLOGY (2013)
A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA
Qing Zhang et al.
GYNECOLOGIC ONCOLOGY (2013)
The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients
Florent Mouliere et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Frequent SLIT2 Promoter Methylation in the Serum of Patients with Ovarian Cancer
R. Dong et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2012)
Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers
Geraldine Perkins et al.
PLOS ONE (2012)
Secreted microRNAs: a new form of intercellular communication
Xi Chen et al.
TRENDS IN CELL BIOLOGY (2012)
Identification of Luminal Breast Cancers That Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells
Hanna S. Kuznetsov et al.
CANCER DISCOVERY (2012)
Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes
Jesse W. Rowley et al.
BLOOD (2011)
Quantitative detection of RASSF1A DNA promoter methylation in tumors and serum of patients with serous epithelial ovarian cancer
Amy E. BonDurant et al.
GYNECOLOGIC ONCOLOGY (2011)
Circulating tumor cells predict progression free survival and overall survival in patients with relapsed/recurrent advanced ovarian cancer
Andres Poveda et al.
GYNECOLOGIC ONCOLOGY (2011)
Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors
Thomas E. Liggett et al.
GYNECOLOGIC ONCOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Impact of platinum-based chemotherapy on circulating nucleic acid levels, protease activities in blood and disseminated tumor cells in bone marrow of ovarian cancer patients
Pauline Wimberger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response
Bogdan Mateescu et al.
NATURE MEDICINE (2011)
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Plasma Cell-Free DNA in Ovarian Cancer An Independent Prognostic Biomarker
Aparna A. Kamat et al.
CANCER (2010)
Microparticles Protagonists of a Novel Communication Network for Intercellular Information Exchange
Sebastian F. Mause et al.
CIRCULATION RESEARCH (2010)
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
Jianghong Li et al.
BMC CANCER (2009)
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer
Tina Fan et al.
GYNECOLOGIC ONCOLOGY (2009)
High-Throughput Proteomics Detection of Novel Splice Isoforms in Human Platelets
Karen A. Power et al.
PLOS ONE (2009)
Delivery of MicroRNA-126 by Apoptotic Bodies Induces CXCL12-Dependent Vascular Protection
Alma Zernecke et al.
SCIENCE SIGNALING (2009)
Metastasis: from dissemination to organ-specific colonization
Don X. Nguyen et al.
NATURE REVIEWS CANCER (2009)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Tumor-specific p53 sequences in blood and peritoneal fluid of women with epithelial ovarian cancer
EM Swisher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
HG Wendel et al.
NATURE (2004)
Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer
PL Judson et al.
GYNECOLOGIC ONCOLOGY (2003)
Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis
C Marth et al.
CANCER (2002)
About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release
M Stroun et al.
CLINICA CHIMICA ACTA (2001)
Share Paper
